首页> 美国卫生研究院文献>Aging (Albany NY) >Intracellular and extracellular S100A9 trigger epithelial-mesenchymal transition and promote the invasive phenotype of pituitary adenoma through activation of AKT1
【2h】

Intracellular and extracellular S100A9 trigger epithelial-mesenchymal transition and promote the invasive phenotype of pituitary adenoma through activation of AKT1

机译:细胞内和细胞外S100a9引发上皮 - 间充质转变通过AKT1激活促进垂体腺瘤的侵袭性表型

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pituitary adenoma (PA) is mostly benign intracranial tumor, but it also displays invasive growth characteristics and provokes challenging clinical conditions. S100A9 protein enhances tumor progression. In this study, we firstly demonstrated that both intracellular and extracellular S100A9 promoted the expression of Vimentin and Intercellular cell adhesion molecule-1 (ICAM-1), coupled with reduced E-cadherin in PA. As a result, PA acquired the phenotype of Epithelial-Mesenchymal Transition (EMT), leading to proliferation, cell cycle progression, migration and invasion. In addition, we indicated S100A9-induced EMT was mediated by activation of AKT1. Furthermore, immunohistochemistry showed that S100A9 expression was higher in invasive PA than that in non-invasive PA. These data extended our understanding for the effects of S100A9 on PA invasion and contributed to further development of a promising therapeutic target for invasive PA.
机译:垂体腺瘤(PA)大多是良性颅内肿瘤,但它也显示出侵入性的生长特征和激发挑战临床状况。 S100A9蛋白增强肿瘤进展。在这项研究中,我们首先证明了细胞内和细胞外S100A9促进了平节和细胞间粘附分子-1(ICAM-1)的表达,同时加上PA中的e-cadherin。结果,PA获得了上皮间充质转换(EMT)的表型,导致增殖,细胞周期进展,迁移和侵袭。此外,我们指出了S100A9诱导的EMT通过AKT1的激活介导。此外,免疫组织化学表明,侵入性PA的S100A9表达比非侵入性PA中的表达更高。这些数据延长了我们对S100A9对PA入侵的影响的理解,并有助于进一步发展侵入性PA的有希望的治疗目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号